Mills-Peninsula Health Services achieved an “A” grade in the Fall 2013 update to the Leapfrog Group’s Hospital Safety Score, which rates how well hospitals protect patients from accidents, errors, injuries and infections.
Calculated twice per year, the Hospital Safety Score uses 28 measures of publicly available hospital safety data to produce an A, B, C, D or F letter grade reflecting how safe hospitals are for patients. Mills-Peninsula has received “straight A” scores since the inception of the Hospital Safety Score in June 2012. Read More about Mills-Peninsula Receives ‘A’ Grade in Hospital Safety Score
For the second consecutive year, the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) has recognized Mills-Peninsula Health Services for achieving high-quality surgical care. Mills-Peninsula was one of 37 hospitals in the country commended for achieving “meritorious outcome performances” in surgery cases from Jan. 1 -Dec. 31, 2012. Sutter Health affiliates California Pacific Medical Center and Alta Bates Summit Medical Center were also recognized.
“It is a great honor to be recognized as one of the top hospitals in the nation for surgical outcomes,” says Bob Merwin, CEO. “We are proud of the hard work and dedication of our entire team, with special thanks to the outstanding leadership of surgeon Bruce Allen, M.D., and Pat Yadao, surgical nurse reviewer in the Quality Management Department.” Read More about Mills-Peninsula Honored for Quality Surgical Care
Mills-Peninsula has received an “A” grade from The Leapfrog Group in its Spring 2013 Hospital Safety Score. This is the third consecutive time Mills-Peninsula has earned an “A” rating for hospital safety from Leapfrog. The Hospital Safety Score grades general acute care hospitals on how safe they are for patients. It is calculated twice each year using publicly available data on preventable medical errors, injuries, accidents and infections at hospitals.
A panel of patient safety experts provided guidance to The Leapfrog Group to calculate the grades from A to F. The panel selected 26 measures of hospital safety data, analyzed the data and determined the weight of each measure.
David C. Klonoff, M.D., FACP, medical director of the Diabetes Research Institute at Mills-Peninsula Health Services, has been elected a Fellow of the American Institute for Medical and Biological Engineering (AIMBE). He will be inducted at the Fellow Induction and Awards Ceremony at AIMBE’s 22nd annual event in February, 2013 in Washington, D.C.
Being named a Fellow is considered one of the highest honors in the biomedical engineering discipline. Fellows represent the top two percent of the medical and biological engineering community.
AIMBE Fellows are leaders in bioengineering who are working to realize the institute’s vision to provide medical and biological engineering innovation for the benefit of humanity. The AIMBE College of Fellows consists of 1,000 individuals who are the outstanding bioengineers in academia, industry and government. These leaders in the field have distinguished themselves through their contributions in research, industrial practice and/or education.
“The mission of AIMBE is to promote public policies to foster advancement in medical and biological engineering,” Dr. Klonoff said. “At the Mills-Peninsula Diabetes Research Institute, we are applying advances in medical and bioengineering to develop new products to help people with diabetes. This award will help call attention to our hospital’s efforts to develop novel engineered devices, drug delivery systems and new medications that are safe and effective in the fight against diabetes, which is the world’s greatest epidemic.”
About Dr. David Klonoff
Dr. David Klonoff founded the Dorothy L. and James E. Frank Diabetes Research Institute of Mills-Peninsula Health Services to facilitate development of new devices and drugs for people with diabetes. He is also a Clinical Professor of Medicine at the University of California, San Francisco (UCSF). Dr. Klonoff’s productivity includes 160 publications, two patents, and 86 clinical trials as principle investigator. Dr. Klonoff chaired the scientific advisory board for developing the first FDA-approved insulin patch pump and participated in development of the first FDA-approved dedicated diabetes telemedicine system, the first FDA-approved inhaled insulin, and the first three FDA-approved incretin drugs for diabetes. He is currently the lead investigator for the first-ever randomized controlled multicenter trial of the world’s first artificial pancreas product for outpatient use. Dr. Klonoff has chaired or served on 34 government grant review panels related to diabetes technology, including panels for National Institutes of Health, the Centers for Disease Control and Prevention, NASA, National Science Foundation, U.S. Army, JDRF, and the University of Michigan.
Mills-Peninsula earned the top score of “A” in The Leapfrog Group’s new report card focused on patient safety at hospitals. This is the second time in two years that The Leapfrog Group has named Mills-Peninsula as one of the top American hospitals for safety and quality.
The scores, conveyed in a letter grade from A to F, can be viewed at hospitalsafetyscore.org. To develop the methodology and calculate the grades, a panel of patient safety experts provided guidance to The Leapfrog Group. The panel selected 26 measures of publicly available hospital safety data, analyzed the data and determined the weight of each measure based on evidence, opportunity for improvement and impact, according to The Leapfrog Group.
“Mills-Peninsula is proud to have earned The Leapfrog Group’s highest grade for patient safety,” says Mills-Peninsula CEO Bob Merwin. “This is great news for our community and is a testament to the hard work and dedication of our entire organization.”
“Leapfrog holds hospitals to the highest standards on behalf of our purchaser members and their employees. Mills-Peninsula has demonstrated exemplary performance across all areas of quality and patient safety that are analyzed on the Leapfrog Hospital Survey. This hospital stands out as one consistently providing safe, high quality care,” said Leah Binder, President and CEO of The Leapfrog Group.
The 26 measures analyzed included the number of patients who develop severe pressure ulcers, have surgical objects left inside their body or develop central line-associated bloodstream infections. They also take into consideration the frequency with which the hospital employs best practices to prevent pneumonia, infections or other complications.
The safety scores also looked at “Structural Measures,” such as whether a hospital uses a computerized physician order entry system (CPOE) to prevent medication errors. Mills-Peninsula achieved the high score of “fully meets standards” for use of CPOE.
Of the 2,652 hospitals issued a Hospital Safety Score, 729 earned an “A,” 679 earned a “B,” and 1,243 earned a “C” or below. Each of the Sutter Health hospitals that received a Hospital Safety Score earned a “C” or higher. Mills-Peninsula is part of the Sutter Health network of care.
The Leapfrog Group is an independent nonprofit run by employers and other large purchasers of health benefits.
The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) has recognized Mills-Peninsula for achieving exemplary outcomes for surgical patient care, reports Bonnie Holland, administrative director, Quality & Regulatory Affairs.
Mills-Peninsula was one of 28 hospitals in the country honored. Alta Bates Summit Medical Center in Oakland, another Sutter Health affiliate, was also recognized.
The ACS NSQIP recognition program commends a select group of hospitals for achieving “exemplary outcomes” in two or more of the following clinical areas: DVT (deep vein thrombosis, thrombophlebitis and pulmonary embolism), cardiac incidents (cardiac arrest and myocardial infarction), respiratory (pneumonia), SSI (surgical site infections-superficial) and urinary tract infection.
The recognition was based on data from general surgery cases from Jan. 1, 2011 to Dec. 31, 2011.The honor was announced at the American College of Surgeons Clinical Congress in October 2012.